June 3, 2021 “Special Edition on the CECP's Biopharma CEO Investor Forum”
Dear Fellow Supporters of Sustainability,
I’d like to extend another invitation to an exceptional free of charge event organized by CECP’s CEO Investor Forum team. The Biopharma CEO Investor Forum (June 7-8) is the premier virtual ESG investor event to hear from leading CEOs on their Long-Term Plans for sustainable value creation, including a live question and answer session with each CEO.
Hear CEO Long-Term Plan presentations from:
- Stéphane Bancel, Chief Executive Officer, Moderna
- Albert Bourla, Chairman and Chief Executive Officer, Pfizer
- John Chiminski, Chair and Chief Executive Officer, Catalent Pharma Solutions
- Kenneth C. Frazier, Chairman and Chief Executive Officer, Merck
- Hervé Hoppenot, Chief Executive Officer, Incyte
- Paul Hudson, Chief Executive Officer, Sanofi
- Jean-Christophe Tellier, Chief Executive Officer & Chairman of the Executive Committee, UCB
- Emma Walmsley, Chief Executive Officer, GSK
- Christophe Weber, President and Chief Executive Officer, Takeda Pharmaceutical Company Ltd.
See the full speaker list and agenda at the website here.
REGISTER TODAY!
Gain complimentary access to the world’s leading biotech and pharmaceutical CEOs thanks to our generous sponsors: Calvert Research and Management and Cowen. We understand time zones can be a challenge to attend so please note that registration will grant you first-access to the recordings when ready.
Guest speakers include: Alex Gorsky, Johnson & Johnson; Bill McNabb, Vanguard; Tensie Whelan, NYU Stern Center for Sustainable Business; Dr. Sanjay Gupta, CNN; Susanne Stormer, PwC; Luke Timmerman, Timmerman Report; Meg Tirrell, CNBC, Andrew Edgecliffe-Johnson, FT; Jeffrey Solomon, Cowen; and more.
If you have any questions, please feel free to reach out to Michael Rosen, Director Capital Markets Engagement, CECP's CEO Investor Forum (mrosen@cecp.co).
|
|
|
|
